Last Updated: August 3, 2025
OneBella™ is an exciting project in early development. Join our movement to build revolutionary diabetes care technology. The features described are being actively developed with input from T1D families.
OneBella™ is a trademark of OneBella Healthcare Solutions. All rights reserved. Unauthorized use of our trademark is prohibited and may result in legal action.
© 2025 OneBella™. All content on this website, including text, graphics, logos, images, and software, is the property of OneBella Healthcare Solutions and is protected by United States and international copyright laws.
OneBella™ is patent pending. The innovative diabetes management technologies, AI-powered analytics, and age-adaptive user experience features described on this website are subject to pending patent applications and intellectual property protections.
OneBella™ is not a medical device. This platform is designed for informational and educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis, or treatment.
OneBella™ follows FDA guidelines for mobile medical applications. Our platform is classified as a wellness device that provides information and tools for diabetes management but does not diagnose, treat, cure, or prevent any disease.
OneBella™ implements medical-grade security standards:
OneBella™ may integrate with third-party services for enhanced functionality. We are not responsible for the privacy practices or content of these third-party services. Please review their terms and privacy policies separately.
To the fullest extent permitted by law, OneBella Healthcare Solutions shall not be liable for any indirect, incidental, special, consequential, or punitive damages, including without limitation, loss of profits, data, use, goodwill, or other intangible losses.
These legal notices are governed by and construed in accordance with the laws of the State of Maine, United States, without regard to conflict of law provisions.
For legal inquiries or concerns:
OneBella™ is committed to transparent and compliant development of healthcare technology that serves the Type 1 diabetes community with the highest standards of safety and privacy.